How GSK Is Experimenting With Seretide-28 In India
Executive Summary
GlaxoSmithKline appears to be experimenting with a tailored version of Seretide Accuhaler (salmeterol/ fluticasone) in India to expand volumes and access to its blockbuster asthma therapy. But some key opinion leaders seem unconvinced of the potential of the mini-pack version in impacting the treatment paradigm materially.